Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein

Author:

Taylor Deborah R.1,Shi Stephanie T.1,Romano Patrick R.2,Barber Glen N.3,Lai Michael M. C.14

Affiliation:

1. Department of Molecular Microbiology and Immunology and

2. Small Molecule Therapeutics, Monmouth Junction, NJ 08852, USA.

3. University of Miami, School of Medicine, Miami, FL 33136, USA.

4. Howard Hughes Medical Institute, University of Southern California, School of Medicine, Los Angeles, CA 90089, USA.

Abstract

Most isolates of hepatitis C virus (HCV) infections are resistant to interferon, the only available therapy, but the mechanism underlying this resistance has not been defined. Here it is shown that the HCV envelope protein E2 contains a sequence identical with phosphorylation sites of the interferon-inducible protein kinase PKR and the translation initiation factor eIF2α, a target of PKR. E2 inhibited the kinase activity of PKR and blocked its inhibitory effect on protein synthesis and cell growth. This interaction of E2 and PKR may be one mechanism by which HCV circumvents the antiviral effect of interferon.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference28 articles.

1. Thomas H. C., Torok M. E., Foster G. R., Hepatology 29, 1333 (1999).

2. M. B. Mathews Translational Control J. W. B. Hershey M. B. Mathews N. Sonenberg Eds. (Cold Spring Harbor Laboratory Press Cold Spring Harbor NY 1996) pp. 505–548.

3. M. J. Gale et al. Virology 230 217 (1997).

4. Enomoto N., et al., N. Engl. J. Med. 334, 77 (1996).

5. M. J. Clemens in (2) pp. 575–605. Four autophosphorylation sites (serine 83 and threonines 88 89 and 90) have been identified in the RNA-binding domain of PKR (D. R. Taylor and M. B. Mathews in preparation). These sequences are not conserved between human and rodent species. These sites and 10 others have been observed by mass spectroscopy by X. Zhang et al. [ Anal. Chem. 70 2050 (1998)].

Cited by 644 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3